De novo membranous glomerulopathy in a renal transplant patient treated with FK 506. The first reported case

International Journal of Artificial Organs

Volumn 20, Issue 7, 1997, Pages 379-382

  Lal, S M ^a   Luger, A M ^a   Hashefi, M ^a   Ross, G ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

De novo membranous nephropathy; FK 506; Proteinuria; Renal transplantation

Indexed keywords

PATIENT TREATMENT;

DE NOVO MEMBRANOI NEPHROPATHY; DIABETICS PATIENTS; FK 506; IMMUNOSUPPRESSIVE AGENT; NEPHROPATHY; PROTEINURIA; RENAL TRANSPLANTATION; RENAL TRANSPLANTS;

PATIENT MONITORING;

ACICLOVIR; AZATHIOPRINE; CIPROFLOXACIN; CLONAZEPAM; CYCLOSPORIN; FUROSEMIDE; INSULIN; METOCLOPRAMIDE; NIFEDIPINE; NORTRIPTYLINE; OKT 3; PENTOXIFYLLINE; PREDNISONE; RANITIDINE; SULBACTAM; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; CASE REPORT; DIABETIC NEPHROPATHY; GRAFT REJECTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; MALE; MEMBRANOUS GLOMERULONEPHRITIS; MICROPHOTOGRAPHY; PROTEINURIA;

EID: 0030770397     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139889702000705     Document Type: Article

References (14)

1. Ramos E, Tisher C. Recurrent diseases in the kidney transplant. Am J Kidney Dis 1994; 24 (1): 142-54.
2. Truong L, Gelfand J, D'Agati V, et al. De novo membranous glomerulopathy in renal allografts: A report of ten cases and review of the literature. Am J Kidney Dis 1989; xiv: 131-44
3. Mathew TM. Recurrence of disease after renal transplantation. Am J Kidney Dis 1988; 12: 85-96.
4. Berger BE, Vincenti F, Biava C, Amend WJ, Feduska N, Salvatierra O. De novo and recurrent membranous glomerulopathy following kidney transplantation. Transplantation 1983; 35: 315-9.
5. Starzl TE, Todo S, Fung J, Demetris AJ, Venkataramman R, Jain A. FK 506 for liver, kidney and pancreas transplantation. Lancet 1989; ii: 1000-4.
6. McCauley J, Shapiro R, Ellis D, Igdal H, Tzakis A, Starzl TE. Pilot trial of FK 506 in the management of steroid-resistant nephrotic syndrome. Nephrol Dial Transplant 1993; 8: 1286-90.
7. McCauley J, Shapiro R, Scantiebury V, et al. FK 506 in the management of transplant related nephrotic syndrome and steroid-resistant nephrotic syndrome. Transplant Proc 1991; 23 (6): 3354-6.
8. Glassock R, Adler SG, Ward JH, Cohen AH. Primary glomerular diseases. In: Brenner and Rector, eds. The Kidney, chap. 26. W.B. Saunders Co. 1991; pp. 1182-1279.
9. Lewis E. Management of the nephrotic syndrome in adults in Cameron JS, Glassock RJ, eds. The nephrotic syndrome. Dekker, New York, 1988; pp. 461-521.
10. Hogan SL, Muller KE, Jennette C, Falk RJ. A Review of therapeutic studies of idiopathic membranous glomerulopathy. Am J Kidney Dis 1995; 25 (6): 862-75.
11. Klouda PT, Manos J, Acheson EJ, et al. Strong association between idiopathic membranous nephropathy and HLA-DR W3. Lancet 1979; 2: 770-1.
12. Schwartz BD, Schreffler DC. Genetic influences on the immune response. In: Parker CW, ed. In clinical immunology, W B. Saunders Co. 1980; p. 49.
13. Berger B, Vincenti F, Biava C, Amend Jr. WJ, Feduska N, Salvatierra Jr. O. De novo and recurrent membranous glomerulopathy following renal transplantation. Transplantation 1983; 35: 315-9.
14. Cosyns J, Pirson Y, Squifflet J, et. al. De novo membranous glomerulopathy in human renal allografts: Report of nine patients. Kidney Int 1982; 22: 177-83.